Show historical bullish cases

Show historical bearish cases

Takeaway: (in order of estimated probability): 1. Steady financial performance continues in near term with modest growth based on core sequencing business (65% probability). 2. Partnerships and move into new markets drive strong revenue growth over next 1-2 years (25% probability). 3. SEC investigation leads to large settlement or breakup of company, disrupting financials (5% probability). 4. Activist investors regain Influence and force additional leadership changes, creating more uncertainty (5% probability). The key takeaway is that while Illumina faces some headwinds, its financial position remains stable for now. But the company needs to leverage partnerships and innovation to return to stronger growth trajectories. Execution of its strategic vision in emerging healthcare and energy markets will be critical for Illumina's future as genomic sequencing alone may provide limited upside.


Show historical takeaways

Potential Outcomes: (in order of estimated probability):

1. Steady financial performance continues in near term with modest growth based on core sequencing business (65% probability).

2. Partnerships and move into new markets drive strong revenue growth over next 1-2 years (25% probability).

3. SEC investigation leads to large settlement or breakup of company, disrupting financials (5% probability).

4. Activist investors regain Influence and force additional leadership changes, creating more uncertainty (5% probability). The key takeaway is that while Illumina faces some headwinds, its financial position remains stable for now. But the company needs to leverage partnerships and innovation to return to stronger growth trajectories. Execution of its strategic vision in emerging healthcare and energy markets will be critical for Illumina's future as genomic sequencing alone may provide limited upside.




Correlated Stock Forecasts

Assets that tend to move strongly with ILMN



CTVA Forecast + Options Trading Strategies   [CTVA]  Corteva (0.72)


AA Forecast + Options Trading Strategies   [AA]  Alcoa (0.59)


CGC Forecast + Options Trading Strategies   [CGC]  Canopy Growth (0.58)


PTON Forecast + Options Trading Strategies   [PTON]  Peloton Interactive (0.51)


ASLE Forecast + Options Trading Strategies   [ASLE]  AerSale (0.51)



Uncorrelated Stock Forecasts

Assets with little price relationship to ILMN



EMN Forecast + Options Trading Strategies   [EMN]  Eastman Chemical (-0.0)


EDC Forecast + Options Trading Strategies   [EDC]  Direxion Daily Emerging Markets Bull 3X Sh (0.01)


EWU Forecast + Options Trading Strategies   [EWU]  BlackRock Institutional (-0.03)


CAR Forecast + Options Trading Strategies   [CAR]  Avis Budget (-0.04)


DWAC Forecast + Options Trading Strategies   [DWAC]  Digital World Acquisition (0.04)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against ILMN



SWK Forecast + Options Trading Strategies   [SWK]  Stanley Black & Decker (-0.49)


OPEN Forecast + Options Trading Strategies   [OPEN]  Opendoor (-0.51)


HSBC Forecast + Options Trading Strategies   [HSBC]  HSBC (-0.51)


CMCSA Forecast + Options Trading Strategies   [CMCSA]  Comcast (-0.52)


TRU Forecast + Options Trading Strategies   [TRU]  TransUnion (-0.57)


ILMN News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.

Most Recent ILMN News